Travoprost Ophthalmic Solution 0.004% "NITTO" (トラボプロスト点眼液0.004%「ニットー」) Japāna - angļu - すりの適正使用協議会 RAD-AR Council, Japan

travoprost ophthalmic solution 0.004% "nitto" (トラボプロスト点眼液0.004%「ニットー」)

nitto medic co., ltd. - travoprost - colorless to pale yellow limpid ophthalmic solution, (cap) light purple, (label) clear, (bottle) clear

SANDOZ TRAVOPROST / TIMOLOL PQ SOLUTION Kanāda - angļu - Health Canada

sandoz travoprost / timolol pq solution

sandoz canada incorporated - travoprost; timolol (timolol maleate) - solution - 0.004%; 0.5% - travoprost 0.004%; timolol (timolol maleate) 0.5% - beta-adrenergic agents

APO-TRAVOPROST-TIMOP PQ SOLUTION Kanāda - angļu - Health Canada

apo-travoprost-timop pq solution

apotex inc - travoprost; timolol (timolol maleate) - solution - 0.004%; 0.5% - travoprost 0.004%; timolol (timolol maleate) 0.5% - beta-adrenergic agents

Bondulc 40 micrograms/ml eye drops, solution Malta - angļu - Medicines Authority

bondulc 40 micrograms/ml eye drops, solution

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - travoprost - eye drops, solution - travoprost 40 µg/ml - ophthalmologicals

TRAVATAN Z- travoprost solution/ drops Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

travatan z- travoprost solution/ drops

novartis pharmaceuticals corporation - travoprost (unii: wj68r08kx9) (travoprost - unii:wj68r08kx9) - travatan z® (travoprost ophthalmic solution) 0.004% is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. none. risk summary there are no adequate and well-controlled studies in pregnant women to inform a drug-associated risk. in animal reproduction studies, subcutaneous (sc) administration of travoprost to pregnant mice and rats throughout the period of organogenesis produced embryo-fetal lethality, spontaneous abortion, and premature delivery at potentially clinically relevant doses. advise pregnant women of a potential risk to a fetus. because animal reproductive studies are not always predictive of human response, travatan z should be administered during pregnancy only if the potential benefit justifies the potential risk to the fetus. the background risk of major birth defects and miscarriage for the indicated population is unknown; however, in the u.s. general population, the estimated background risk of major birth defects is

Travon eye drops Kenija - angļu - Pharmacy and Poisons Board

travon eye drops

indoco remedies limited "indoco house, 166, cst road, santacruz (east), - travoprost - eye drops - each ml contains: travoprost 0.04 mg - travoprost